1 Wieland I, "Twenty-six novel EFNB1 mutations in familial and sporadic craniofrontonasal syndrome (CFNS)" 26 : 113-118, 2005
2 Kwan Tat S, "Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes" 11 : R119-, 2009
3 Cheng S, "Transgenic overexpression of ephrin B1 in bone cells promotes bone formation and an anabolic response to mechanical loading in mice" 8 : e69051-, 2013
4 Martin-Rendon E, "Transcriptional profiling of human cord blood CD133þ and cultured bone marrow mesenchymal stem cells in response to hypoxia" 1003-1012, 2007
5 Eppig JT, "The mouse genome database (MGD): facilitating the mouse as a model for human biology and disease" 43 : D726-D736, 2015
6 Flanagan JG, "The ephrins and Eph receptors in neural development" 21 : 309-345, 1998
7 Campbell TN, "The Eph receptor/ephrin system: an emerging player in the invasion game" 10 : 61-66, 2008
8 Shenolikar S, "Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting" 99 : 11470-11475, 2002
9 Cheng S, "Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice" 3 : e32887-, 2012
10 Hong JH, "TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation" 5 : 176-179, 2006
11 Hong JH, "TAZ, a transcriptional modulator of mesenchymal stem cell differentiation" 309 : 1074-1078, 2005
12 Adams RH, "Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis" 13 : 295-306, 1999
13 Robinson V, "Roles of Eph receptors and ephrins in neural crest pathfinding" 290 : 265-274, 1997
14 Zhang J, "Role of the ephrin and eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system" 208 : 453-461, 2006
15 Kim J, "Rewiring of PDZ domain-ligand interaction network contributed to eukaryotic evolution" 8 : e1002510-, 2012
16 Kuijper S, "Regulation of angiogenesis by Ephephrin interactions" 17 : 145-151, 2007
17 Ardura JA, "Regulation of G protein-coupled receptor function by Naþ/Hþ exchange regulatory factors" 63 : 882-900, 2011
18 Mao Y, "Preliminary identification of potential PDZ-domain proteins downstream of ephrin B2 during osteoclast differentiation of RAW264.7 cells" 27 : 669-677, 2011
19 Ivarsson Y, "Plasticity of PDZ domains in ligand recognition and signaling" 586 : 2638-2647, 2012
20 Beuming T, "PDZBase:a protein-protein interaction database for PDZ-domains" 21 : 827-828, 2005
21 Yang JY, "Osteoblasttargeted overexpression of TAZ increases bone mass in vivo" 8 : e56585-, 2013
22 Hong D, "Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells" 116 : 86-92, 2009
23 Wang B, "NHERF1 regulation of PTH-dependent bimodal Pi transport in osteoblasts" 52 : 268-277, 2013
24 Stadler HS, "Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs" 128 : 4177-4188, 2001
25 Naruse-Nakajima C, "Involvement of EphA2 in the formation of the tail notochord via interaction with ephrinA1" 102 : 95-105, 2001
26 Wada N, "Glycosylphosphatidylinositol-anchored cell surface proteins regulate positionspecific cell affinity in the limb bud" 202 : 244-252, 1996
27 Duffy SL, "Generation and characterization of EphA1 receptor tyrosine kinase reporter knockout mice" 46 : 553-561, 2008
28 Liu H, "EphrinBmediated reverse signaling controls junctional integrity and proinflammatory differentiation of endothelial cells" 112 : 151-163, 2014
29 Takyar FM, "EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone" 28 : 912-925, 2013
30 Tonna T, "EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis" 28 : 4482-4496, 2014
31 Allan EH, "EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts" 23 : 1170-1181, 2008
32 Palmer A, "EphrinB phosphorylation and reverse signaling:regulation by Src kinases and PTP-BL phosphatase" 9 : 725-737, 2002
33 Kao T-J, "Ephrin-mediated cis-attenuation of Eph receptor signaling is essential for spinal motor axon guidance" 71 : 76-91, 2011
34 Gale NW, "Ephrin-B2 selectivity marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells" 230 : 151-160, 2001
35 Davy A, "Ephrin-B2 forward signaling regulates somite patterning and neural crest cell development" 304 : 182-193, 2007
36 Foo SS, "Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly" 124 : 161-173, 2006
37 Wang Y, "Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis" 465 : 483-486, 2010
38 Huynh-Do U, "Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis" 115 : 3073-3081, 2002
39 Bush JO, "Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism" 23 : 1586-1599, 2009
40 Bush JO, "Ephrin-B1 forward signaling regulates craniofacial morphogenesis by controlling cell proliferation across Eph-ephrin boundaries" 24 : 2068-2080, 2010
41 Davy A, "Ephrin-B1 forward and reverse signaling are required during mouse development" 18 : 572-583, 2004
42 Benson MD, "Ephrin-B stimulation of calvarial bone formation" 241 : 1901-1910, 2012
43 Davy A, "Ephrin signaling in vivo: look both ways" 232 : 1-10, 2005
44 San Miguel S, "Ephrin reverse signaling controls palate fusion via a PI3kinase-dependent mechanism" 240 : 357-364, 2011
45 Nagano K, "Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers" 189 : 72-79, 2014
46 Wang Y, "Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation" 29 : 1900-1913, 2014
47 Xing W, "Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1" 30 : 711-721, 2010
48 Nguyen TM, "EphB4 expressing stromal cells exhibit an enhanced capacity for hematopoietic stem cell maintenance" 33 : 2838-2849, 2015
49 Arthur A, "EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair" 926-935, 2013
50 Risley M, "EphB2 and EphB3 forward signaling are required for palate development" 126 : 230-239, 2009
51 Nguyen TM, "EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells" 22 : 2751-2764, 2013
52 Stiffel V, "EphA4 is a novel negative regulator of osteoclast activity" 29 : 804-819, 2014
53 Ting M-C, "EphA4 as an effector of Twist1 in the guidance of osteogenic precursor cells during calvarial bone growth and in craniosynostosis" 136 : 855-864, 2009
54 Miao H, "EphA receptor signaling-Complexity and emerging themes" 23 : 16-25, 2012
55 Luxey M, "Eph:ephrin-B1 forward signaling controls fasciculation of sensory and motor axons" 383 : 264-274, 2013
56 Arthur A, "Eph/ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation" 48 : 533-542, 2011
57 Arvanitis D, "Eph/ephrin signaling: networks" 22 : 416-429, 2008
58 Klein R, "Eph/ephrin signaling during development" 139 : 4105-4109, 2012
59 Stark DA, "Eph/ephrin interactions modulate muscle satellite cell motility and patterning" 138 : 5279-5289, 2011
60 Pasquale EB, "Eph receptors and ephrins in cancer: bidirectional signaling and beyond" 10 : 165-180, 2010
61 Himanen JP, "Eph receptors and ephrins" 35 : 130-134, 2003
62 Edwards CM, "Eph receptors and ephrin signaling pathways:a role in bone homeostasis" 5 : 263-272, 2008
63 Kitamura T, "Ehnacement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis" 294 : C189-C196, 2008
64 Sims NA, "EPHs and ephrins: many pathways to regulate osteoblasts and osteoclasts" 7 : 304-313, 2010
65 Genander M, "Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression" 139 : 679-692, 2009
66 Compagni A, "Control of skeletal patterning by ephrinB1-EphB interactions" 5 : 217-230, 2003
67 Kesavan C, "Conditional disruption of IGF-I gene in type 1a collagen-expressing cells shows an essential role of IGF-I in skeletal anabolic response to loading" 301 : 1191-1197, 2011
68 Marquardt T, "Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains" 121 : 127-139, 2005
69 Tonna S, "Chondrocytic ephrinB2 promotes cartilage destruction by osteoclasts in endochondral ossification" 143 : 648-657, 2016
70 Merrill AE, "Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis" 15 : 1319-1328, 2006
71 Matsuo K, "Bone cell interactions through Eph/ephrin. Bone modeling, remodeling and associated diseases" 6 : 148-156, 2012
72 Cheng N, "Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis" 1 : 2-11, 2002
73 Irie N, "Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis" 284 : 14637-14644, 2009
74 Zhao C, "Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis" 4 : 111-121, 2006
75 Laussu J, "Beyond boundaries-Eph/ephrin signaling in neurogenesis" 8 : 349-359, 2014
76 Shimizu E, "Alendronate affects osteoblast functions by crosstalk through ephrinB1/EphB" 91 : 268-274, 2012
77 Kwan Tat S, "Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts" 58 : 3820-3830, 2008
78 Coulthard MG, "4Eph/ephrin signaling in injury and inflammation" 181 : 1493-1503, 2012